Perkins Capital Management Inc Buys Interpace Biosciences Inc, CareDx Inc, Gilead Sciences Inc, Sells Interpace Biosciences Inc, Aflac Inc, Microvision Inc

• New Purchases: PF42, GILD, ITMR, SE8, DGII, TRXC, OCX, ONTX, AGRX, EFOI, 04IC, SIEN, CPST,
• Added Positions: CDNA, BEAT, RMTI, VG, ATEC, PFIE, INUV, MMM, AVGR, FPAY, IIN, FLDM, ASPU, MRK, ATRC, LMAT, PDCO, BIOL, IRIX, SENS,
• Reduced Positions: VERI, NEO, VCYT, BLFS, NTRA, TGT, BSX, RUBI, VCEL, CVS, AMD, CSBR, APPS, CSII, CYRX, ATRS, QKL1, HTGM, AMRN, QUMU, IDXX, CIEN, T, AKTS, OPRX, OPCH, KRMD, ASUR, USB, TYME, VRAY, ABBV, STRM, BMY, AIRG, OOMA, FEYE, ELGX, ATHX, GIS,
• Sold Out: IDXG, AFL, MVIS, JYNT, CEMI, ANIP, HEAR, DLX, PRFT, TBN2, BBY, SPWH, INGN, NVIV, RLGT, 0RR1, TTSH, BKYI,

For the details of PERKINS CAPITAL MANAGEMENT INC's stock buys and sells, go to https://www.gurufocus.com/guru/perkins+capital+management+inc/current-portfolio/portfolio

1. NeoGenomics Inc (NEO) - 234,850 shares, 8.07% of the total portfolio. Shares reduced by 6.99%
2. Vericel Corp (VCEL) - 344,397 shares, 3.93% of the total portfolio. Shares reduced by 2.59%
3. Axogen Inc (AXGN) - 298,240 shares, 3.86% of the total portfolio. Shares added by 0.49%
4. Veracyte Inc (VCYT) - 121,730 shares, 3.68% of the total portfolio. Shares reduced by 8.22%
5. IDEXX Laboratories Inc (IDXX) - 11,205 shares, 3.38% of the total portfolio. Shares reduced by 1.28%

Perkins Capital Management Inc initiated holding in Interpace Biosciences Inc. The purchase prices were between $0.58 and $9.8, with an estimated average price of $6.33. The stock is now traded at around $4.76. The impact to a portfolio due to this purchase was 1.45%. The holding were 224,107 shares as of .

Perkins Capital Management Inc initiated holding in Gilead Sciences Inc. The purchase prices were between $62.63 and $80.22, with an estimated average price of $68.92. The stock is now traded at around $83.98. The impact to a portfolio due to this purchase was 0.99%. The holding were 10,600 shares as of .

Perkins Capital Management Inc initiated holding in Itamar Medical Ltd. The purchase prices were between $7.95 and $17.54, with an estimated average price of $13.69. The stock is now traded at around $14.61. The impact to a portfolio due to this purchase was 0.29%. The holding were 20,000 shares as of .

Perkins Capital Management Inc initiated holding in SenesTech Inc. The purchase prices were between $1.38 and $10.5, with an estimated average price of $5.32. The stock is now traded at around $2.14. The impact to a portfolio due to this purchase was 0.21%. The holding were 81,875 shares as of .

Perkins Capital Management Inc initiated holding in Digi International Inc. The purchase prices were between $6.4 and $17.72, with an estimated average price of $13.97. The stock is now traded at around $12.08. The impact to a portfolio due to this purchase was 0.13%. The holding were 10,800 shares as of .

Perkins Capital Management Inc initiated holding in TransEnterix Inc. The purchase prices were between $0.29 and $1.64, with an estimated average price of $1.06. The stock is now traded at around $0.44. The impact to a portfolio due to this purchase was 0.1%. The holding were 224,117 shares as of .

Perkins Capital Management Inc added to a holding in CareDx Inc by 51.15%. The purchase prices were between $13.94 and $28.25, with an estimated average price of $22.48. The stock is now traded at around $26.96. The impact to a portfolio due to this purchase was 1.13%. The holding were 122,633 shares as of .

Perkins Capital Management Inc added to a holding in BioTelemetry Inc by 65.18%. The purchase prices were between $28.93 and $55.27, with an estimated average price of $46.28. The stock is now traded at around $48.26. The impact to a portfolio due to this purchase was 0.73%. The holding were 38,735 shares as of .

Perkins Capital Management Inc added to a holding in Rockwell Medical Inc by 29.93%. The purchase prices were between $1.56 and $3.57, with an estimated average price of $2.59. The stock is now traded at around $2.42. The impact to a portfolio due to this purchase was 0.57%. The holding were 965,900 shares as of .

Perkins Capital Management Inc added to a holding in Vonage Holdings Corp by 63.26%. The purchase prices were between $4.53 and $10.7, with an estimated average price of $8.16. The stock is now traded at around $8.44. The impact to a portfolio due to this purchase was 0.54%. The holding were 155,550 shares as of .

Perkins Capital Management Inc added to a holding in Alphatec Holdings Inc by 117.15%. The purchase prices were between $2.26 and $7.47, with an estimated average price of $5.81. The stock is now traded at around $4.88. The impact to a portfolio due to this purchase was 0.43%. The holding were 186,750 shares as of .

Perkins Capital Management Inc added to a holding in Profire Energy Inc by 70.70%. The purchase prices were between $0.7 and $1.5, with an estimated average price of $1.23. The stock is now traded at around $0.78. The impact to a portfolio due to this purchase was 0.43%. The holding were 1,049,489 shares as of .

Perkins Capital Management Inc sold out a holding in Interpace Biosciences Inc. The sale prices were between $4.9 and $10.55, with an estimated average price of $7.25.

Perkins Capital Management Inc sold out a holding in Aflac Inc. The sale prices were between $25.27 and $53.42, with an estimated average price of $46.04.

Perkins Capital Management Inc sold out a holding in Microvision Inc. The sale prices were between $0.17 and $0.77, with an estimated average price of $0.51.

Perkins Capital Management Inc sold out a holding in The Joint Corp. The sale prices were between $8.14 and $17.3, with an estimated average price of $14.74.

Perkins Capital Management Inc sold out a holding in Chembio Diagnostics Inc. The sale prices were between $2.36 and $5.6, with an estimated average price of $4.05.

Perkins Capital Management Inc sold out a holding in ANI Pharmaceuticals Inc. The sale prices were between $30.35 and $67.14, with an estimated average price of $53.63.